A Study With CIT-013 in RA Patients
Conditions
Rheumatoid Arthritis
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
BE-02, Antwerp, Belgium
Site BE-01, Leuven, Belgium
Contact: Study coordinator (PI BE-01)DE-04, Bamberg, Germany
Contact: Study coordinator (PI DE-04)DE-05, Berlin, Germany
Contact: Study coordinator (PI DE-05)DE-01, München, Germany
Contact: Study coordinator (PI DE-01)DE-02, München, Germany
Contact: Study coordinator (PI DE-02)DE-03, Ratingen, Germany
NL-02, Amsterdam, Netherlands
NL-05, Leeuwarden, Netherlands
Contact: Study coordinator (PI NL-05)NL-04, Leiden, Netherlands
NL-03, Nijmegen, Netherlands
Contact: Study coordinator (PI NL-03)NL-01, Rotterdam, Netherlands
Contact: Study coordinator (PI NL-01)PL-01, Bialystok, Poland
Contact: Study coordinator (PI PL-01)PL-07, Krakow, Poland
Contact: Study coordinator (PI PL-07)PL-03, Lublin, Poland
Contact: Study coordinator (PI PL-03)PL-02, Poznan, Poland
Contact: Study coordinator (PI PL-02)PL-05, Torun, Poland
Contact: Study coordinator (PI PL-05)PL-04, Warsaw, Poland
Contact: Study coordinator (PI PL-04)ES-02, A Coruña, Spain
Contact: Study coordinator (PI ES-02)ES-04, Barcelona, Spain
Contact: Study coordinator (PI ES-04)ES-05, Barcelona, Spain
Contact: Study coordinator (PI ES-05)ES-06, Madrid, Spain
Contact: Study coordinator (PI ES-06)ES-01, Santander, Spain
Contact: Study coordinator (PI ES-01)ES-03, Santiago de Compostela, Spain
Contact: Study coordinator (PI ES-03)
Study leads
Maarten Kraan
Study Director
Citryll BV